nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer's disease biomarker states
|
Vos, Stephanie J B |
|
2016 |
15 |
1 |
p. 25-26 2 p. |
artikel |
2 |
A tale of split-brain research
|
Bagcchi, Sanjeet |
|
2016 |
15 |
1 |
p. 34- 1 p. |
artikel |
3 |
Building on 50 years of levodopa therapy
|
The Lancet Neurology, |
|
2016 |
15 |
1 |
p. 1- 1 p. |
artikel |
4 |
Cathy Goldstein
|
|
|
2016 |
15 |
1 |
p. 32- 1 p. |
artikel |
5 |
CNS infections in 2015: emerging catastrophic infections and new insights into neuroimmunological host damage
|
Williamson, Peter R |
|
2016 |
15 |
1 |
p. 17-19 3 p. |
artikel |
6 |
Comorbidities of epilepsy: current concepts and future perspectives
|
Keezer, Mark R |
|
2016 |
15 |
1 |
p. 106-115 10 p. |
artikel |
7 |
Comorbidity as an epidemiological construct
|
Keezer, Mark R |
|
2016 |
15 |
1 |
p. 32- 1 p. |
artikel |
8 |
Corrections
|
|
|
2016 |
15 |
1 |
p. 28- 1 p. |
artikel |
9 |
Degenerative neuromuscular diseases: crucial gene and cell machinery discoveries
|
ChiĆ², Adriano |
|
2016 |
15 |
1 |
p. 12-13 2 p. |
artikel |
10 |
Dementia in western Europe: epidemiological evidence and implications for policy making
|
Wu, Yu-Tzu |
|
2016 |
15 |
1 |
p. 116-124 9 p. |
artikel |
11 |
Dr No: double drug fails to eliminate status epilepticus
|
Claassen, Jan |
|
2016 |
15 |
1 |
p. 23-24 2 p. |
artikel |
12 |
Epilepsy in 2015: the year of collaborations for big data
|
Ben-Menachem, Elinor |
|
2016 |
15 |
1 |
p. 6-7 2 p. |
artikel |
13 |
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
|
Voskuhl, Rhonda R |
|
2016 |
15 |
1 |
p. 35-46 12 p. |
artikel |
14 |
Headache research in 2015: progress in migraine treatment
|
Diener, Hans-Christoph |
|
2016 |
15 |
1 |
p. 4-5 2 p. |
artikel |
15 |
Movement disorders: advances in 2015
|
Hattori, Nobutaka |
|
2016 |
15 |
1 |
p. 8-9 2 p. |
artikel |
16 |
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study
|
Morrow, Jasper M |
|
2016 |
15 |
1 |
p. 65-77 13 p. |
artikel |
17 |
MRI quantifies neuromuscular disease progression
|
Forbes, Sean C |
|
2016 |
15 |
1 |
p. 26-28 3 p. |
artikel |
18 |
Multiple sclerosis and related disorders: evolving pathophysiologic insights
|
Bar-Or, Amit |
|
2016 |
15 |
1 |
p. 9-11 3 p. |
artikel |
19 |
Neuro-scientific enlightenment in Scotland?
|
Ranscombe, Peter |
|
2016 |
15 |
1 |
p. 33- 1 p. |
artikel |
20 |
Plasticity of pain revisited in 2015
|
Jensen, Troels S |
|
2016 |
15 |
1 |
p. 19-21 3 p. |
artikel |
21 |
Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial
|
Navarro, Vincent |
|
2016 |
15 |
1 |
p. 47-55 9 p. |
artikel |
22 |
Reflex seizures, traits, and epilepsies: from physiology to pathology
|
Koepp, Matthias J |
|
2016 |
15 |
1 |
p. 92-105 14 p. |
artikel |
23 |
Sex hormones and multiple sclerosis: another informative failure
|
Langer-Gould, Annette |
|
2016 |
15 |
1 |
p. 22-23 2 p. |
artikel |
24 |
Stroke in 2015: the year of endovascular treatment
|
Muir, Keith W |
|
2016 |
15 |
1 |
p. 2-3 2 p. |
artikel |
25 |
The huge burden of dementia in Latin America
|
Manes, Facundo |
|
2016 |
15 |
1 |
p. 29- 1 p. |
artikel |
26 |
Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study
|
Jack Jr, Clifford R |
|
2016 |
15 |
1 |
p. 56-64 9 p. |
artikel |
27 |
Traumatic brain injury research highlights in 2015
|
Kochanek, Patrick M |
|
2016 |
15 |
1 |
p. 13-15 3 p. |
artikel |
28 |
Uganda: how goes the nodding syndrome war?
|
Burton, Adrian |
|
2016 |
15 |
1 |
p. 30-31 2 p. |
artikel |
29 |
Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions
|
Markey, Keira A |
|
2016 |
15 |
1 |
p. 78-91 14 p. |
artikel |
30 |
Waking up to sleep research in 2015
|
Goldstein, Cathy |
|
2016 |
15 |
1 |
p. 15-17 3 p. |
artikel |